When Rheumatoid Arthritis Biologics Fail
November 12, 2010|Rheumatology News
Author and Disclosure Information
Rheumatoid arthritis patients who fail on a first-time trial of tumor necrosis factor inhibitor therapy should change to a biologic with a different mechanism of action, explains Dr. Daniel E. Furst.